Diabetes
Dexcom Solidifies Global Leadership in Continuous Glucose Monitoring With New Clinical Data Presented at EASD
02/10/2023 — SAN DIEGO — (BUSINESS WIRE) DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today new clinical study outcomes that […]
Fresenius Kabi Launches Single-Needle Option for the Amicus® Extracorporeal Photopheresis Protocol
23/04/2023 — PARIS — (BUSINESS WIRE) Fresenius Kabi today announced the availability of a single-needle venous access option for the Amicus® Extracorporeal Photopheresis (ECP) System at the 49th annual meeting […]
Dexcom Showcases Accuracy, Simplicity and Connectivity of Its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally
22/02/2023 — SAN DIEGO — (BUSINESS WIRE) DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will showcase the strength of its […]
Oxular Limited Announces Acceptance of IND for Suprachoroidal OXU-001 for the Treatment of Diabetic Macular Edema
OXU-001 represents potential best-in-class treatment for DME with just one, targeted administration per year Initiation of OXEYE Phase 2 clinical trial of OXU-001 in DME patients on-track for first quarter […]
Medimaps Group Appoints Meinhard F. Schmidt as Board Chairman; Adds Anne Le Grand and Five Additional Board Members
28/11/2022 — GENEVA — (BUSINESS WIRE) Medimaps Group (www.medimapsgroup.com), a Swiss/Global med-tech company specializing in image processing software for assessing bone health, today announced new appointments to its Board of […]
Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World’s Most Powerful Continuous Glucose Monitoring System
People with diabetes in the United Kingdom, Ireland, Germany, Austria and Hong Kong can get started with Dexcom G7 now The new CGM system is also expected to launch in […]
DexCom Showcases Expanded CGM Portfolio at International ATTD Conference, Offering More Choice to People With Diabetes
New portfolio of continuous glucose monitoring systems includes Dexcom ONE, Dexcom G6 and the upcoming Dexcom G7, which recently received CE Mark and is currently under FDA review1 The expanded […]
Dexcom Looks to the Future of Continuous Glucose Monitoring
Results of two new studies illustrate continued momentum for Dexcom CGM, including JAMA-published data on additional populations who can benefit from the technology 03/06/2021 — SAN DIEGO — (BUSINESS WIRE) […]
Xeris Pharmaceuticals Receives European Commission Approval of Ogluo™ (glucagon) Injection for the Treatment of Severe Hypoglycaemia in Adults, Adolescents, and Children Aged 2 Years and Over With Diabetes Mellitus
OGLUO™ Europe’s first and only ready-to-use liquid glucagon for rescue First availability expected in the fourth quarter Approval supported by data from pivotal Phase 3 study 12/02/2021 — CHICAGO & […]
European Steering Committee launch ‘A New Era in Diabetes Care’ report highlighting the need to improve the quality of care for people with type 2 diabetes and renal / cardiovascular complications
‘A New Era in Diabetes Care’ is an initiative bringing together a group of eight diabetes, nephrology and primary care experts from across Europe, to discuss key challenges and opportunities […]
Senseonics Announces CE Mark Approval for Eversense® XL CGM System
Advanced CGM Technology with Extended Long-Term Wear of up to 180 Days 12/09/2017 — GERMANTOWN, Md. — (BUSINESS WIRE) Senseonics Holdings, Inc. (NYSE-MKT-SENS) today announced it has received CE Mark […]
Second Global NCD Alliance Forum to be Held in Sharjah, UAE in December 2017
On the side lines of the 71st UN General Assembly in New York 19/09/2016 — NEW YORK — (BUSINESS WIRE) The NCD Alliance yesterday evening announced that the second Global […]
Senseonics Reports Topline Accuracy Results from U.S. Pivotal Study of Eversense CGM System.
Topline Accuracy of 8.8% MARD (Mean Absolute Relative Difference) over 90 Days. 09/08/2016 — GERMANTOWN, Md. — (BUSINESS WIRE) Senseonics Holdings, Inc. (NYSE-MKT:SENS), a medical technology company focused on the development […]